Judge rules Mentzelopoulos must return records as part of wrongful dismissal lawsuit - CBC

CalgaryA judge ordered Alberta Health Services and the province to produce records to fill "certain gaps and deficiencies" tied to a lawsuit launched by the former CEO of AHS. Records ‘very important’ to Mentzelopoulos’ claims: lawyerJoel Dryden · CBC News · Posted: Oct 05, 2026 6:22 PM EDT | Last Updated: October 5Listen to this articleEstimated 4 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Athana Mentzelopoulos, former CEO of Alberta Health Services, is suing the provincial government and AHS for wrongful dismissal. She is seen outside the law courts in Edmonton on April 29. (Lisa Johnson/The Canadian Press)A judge has ordered Alberta Health Services and the province to produce records to fill "certain gaps and deficiencies" tied to a lawsuit launched by the former CEO of AHS. In February 2025, Athana Mentzelopoulos filed a $1.7-million lawsuit for wrongful dismissal against AHS and the provincial government.

Founder and former president, CEO and chairman, Lynn Mueller, claims that he was denied notice and severance

Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.

European Medical Journal news storyPeople living with HIV may experience subtle changes in heart muscle function even when conventional measures of cardiac performance remain normal, according to findings from a systematic review and meta-analysis. Researchers identified significantly impaired global longitudinal strain (GLS) among people with HIV compared with HIV-uninfected individuals, despite preserved left ventricular ejection fraction (LVEF) in both groups. The findings suggest that speckle-tracking echocardiography (STE) could provide additional information about early myocardial dysfunction in this population. Read the full news story here.